Impact of probiotics on colonic microflora in patients with colitis: Aprospective double blind randomised crossover study

International Journal of Surgery

Volumn 11, Issue 10, 2013, Pages 1131-1136

  Ahmed, Jamil ^a   Reddy, Bala S ^a   Mølbak, Lars ^b   Leser, Thomas D ^c   MacFie, John ^a  

^a SCARBOROUGH HOSPITAL   (United Kingdom)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c CHR HANSEN A S   (Denmark)

Author keywords

Colitis; Inflammatory bowel disease; Probiotics

Indexed keywords

LA 5; LACTIS BB 12; LANTHANUM; PLACEBO; STY 31; SYNBIOTIC AGENT; TREVIS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLUSTER ANALYSIS; COLON CROHN DISEASE; COLON FLORA; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FEMALE; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT DURATION; ULCERATIVE COLITIS;

COLITIS; INFLAMMATORY BOWEL DISEASE; PROBIOTICS;

AGED; BACTERIA; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-OVER STUDIES; DNA, BACTERIAL; DOUBLE-BLIND METHOD; FECES; HUMANS; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROBIOTICS; PROSPECTIVE STUDIES;

EID: 84889094301     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2013.08.019     Document Type: Article

References (19)

1. Bamias G., Nyce M.R., De La Rue S.A., et al. New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med 2005, 143(12):895-904.
2. Seksik P., Rigottier-Gois L., Gramet G., et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003, 52(2):237-242.
3. Keighley M.R., Arabi Y., Dimock F., et al. Influence of inflammatory bowel disease on intestinal microflora. Gut 1978, 19(12):1099-1104.
4. Harper P.H., Lee E.C., Kettlewell M.G., et al. Role of the faecal stream in the maintenance of Crohn's colitis. Gut 1985, 26(3):279-284.
5. Hisamatsu T., Suzuki M., Reinecker H.C., et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003, 124(4):993-1000.
6. Guslandi M., Mezzi G., Sorghi M., et al. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000, 45(7):1462-1464.
7. Fedorak R.N. Understanding why probiotic therapies can be effective in treating IBD. JClin Gastroenterol 2008, 42(Suppl.3 Pt 1):S111-S115.
8. Sartor R.B. Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr Opin Gastroenterol 2003, 19(4):358-365.
9. Hegazy S.K., El-Bedewy M.M. Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis. World J Gastroenterol 2010, 16(33):4145-4151.
10. Uronis J.M., Arthur J.C., Keku T., et al. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm Bowel Dis 2010, 17(1):289-297.
11. Liu W.T., Marsh T.L., Cheng H., et al. Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA. Appl Environ Microbiol 1997, 63(11):4516-4522.
12. Molbak L., Thomsen L.E., Jensen T.K., et al. Increased amount of Bifidobacterium thermacidophilum and Megasphaera elsdenii in the colonic microbiota of pigs fed a swine dysentery preventive diet containing chicory roots and sweet lupine. JAppl Microbiol 2007, 103(5):1853-1867.
13. Leser T.D., Amenuvor J.Z., Jensen T.K., et al. Culture-independent analysis of gut bacteria: the pig gastrointestinal tract microbiota revisited. Appl Environ Microbiol 2002, 68(2):673-690.
14. Malinen E., Kassinen A., Rinttilä T., et al. Comparison of real-time PCR with SYBR Green I or 5'-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 2003, 149(Pt 1):269-277.
15. Rabizadeh S., Rhee K.J., Wu S., et al. Enterotoxigenic bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis 2007, 13(12):1475-1483.
16. Prindiville T.P., Sheikh R.A., Cohen S.H., et al. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg Infect Dis 2000, 6(2):171-174.
17. Sang L.X., Chang B., Zhang W.L., et al. Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis. World J Gastroenterol 2010, 16(15):1908-1915.
18. Bai A.P., Ouyang Q. Probiotics and inflammatory bowel diseases. Postgrad Med J 2006, 82(968):376-382.
19. Vanderpool C., Yan F., Polk D.B. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008, 14(11):1585-1596.